IDH2 and central nervous system cancer: Furthermore, PD-1 methylation was prognostic for survival in lower-grade gliomas harboring isocitrate dehydrogenase (IDH) mutations supporting the pivotal role of DNA methylation in the regulation of immune checkpoint genes in gliomas.